Unlocking the therapeutic potential of drug combinations through synergy prediction using graph transformer networks

Waleed Alam1, Hilal Tayara2, Kil To Chong3

  • 1Department of Electronics and Information Engineering, Jeonbuk National University, Jeonju, 54896, South Korea.

PubMed

Insights

A new computational model, SynergyGTN, uses deep learning to predict synergistic drug combinations for cancer treatment. This approach is more efficient and accurate than existing methods, aiding drug discovery.

Area of Science:

  • Computational biology
  • Bioinformatics
  • Drug discovery

Background:

  • Drug combinations are crucial for cancer therapy, improving efficacy and reducing side effects.
  • Experimental identification of synergistic drug combinations is costly and time-consuming for large datasets.
  • Deep learning offers a powerful computational approach for analyzing complex biological data.

Purpose of the Study:

  • To develop an efficient and reliable computational model for predicting synergistic drug combinations against cancer cell lines.
  • To leverage Graph Transformer Networks (GTN) for drug synergy prediction.

Main Methods:

  • Developed SynergyGTN, a model based on Graph Transformer Network (GTN).
  • Represented drugs as graphs with atomic feature vectors and bond features.
  • Integrated drug graph features with cancer cell line gene expression profiles.
  • Utilized densely connected layers for final prediction.

Main Results:

  • SynergyGTN demonstrated superior performance compared to state-of-the-art methods.
  • Achieved a 5% improvement in receiver operating characteristic area under the curve (ROC AUC) via 5-fold cross-validation.
  • Showcased enhanced accuracy across leave-drug-out (8%), leave-combination-out (1%), and leave-tissue-out (2%) validation strategies.
  • Validated generalizability on the Astrazeneca Dream dataset, yielding a 13% improvement in balanced accuracy.

Conclusions:

  • SynergyGTN provides a reliable and efficient computational method for predicting synergistic drug combinations in cancer treatment.
  • The developed SynergyGTN model and its associated web server tool can significantly aid the pharmaceutical industry and researchers in drug discovery efforts.

Related Concept Videos

Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
3.9K
Agonism and Antagonism: Quantification01:14

Agonism and Antagonism: Quantification

When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
376
Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.9K
Protein Networks02:26

Protein Networks

An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
4.0K
Combined Effects of Drugs: Antagonism01:30

Combined Effects of Drugs: Antagonism

The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
8.5K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
726